Source: The Business Journals: Raleigh/Durham

Bain Capital: Gene therapy firm secures $150M round led by Bain Capital

A Durham company is aiming to develop innovative treatments for a rare form of blindness.

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
John Connaughton's photo - Managing Partner of Bain Capital

Managing Partner

John Connaughton

CEO Approval Rating

86/100

Read more